Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company’s Class A common stoc ...

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growt ...

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growt ...

Boston, June 13, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that co-founder and visionary healthcare technology leader Roy Schoenberg, M.D., M.P.H., is transitioning from his role as president and co-CEO to become Executive Vice Chairman of Amwell’s Board of Directors. Ido Schoenberg, M.D., will assume the role of sole Chief Executive Officer of Amwell. Since co-founding Amwell in 2006, Roy Schoenberg has been a driving force behind the nation’s embrace of digit ...

财务数据和关键指标变化 - 总收入为5.95亿美元,同比下降7% [26][27] - 订阅收入为2.49亿美元,环比下降9% [26] - 访问量为167万次,同比略有下降 [25] - 毛利率为31%,环比下降约300个基点 [30] 各条业务线数据和关键指标变化 - 虚拟就诊业务收入为3.1亿美元,同比下降4% [28] - 服务和Carepoints收入为360万美元,环比下降 [29] 各个市场数据和关键指标变化 - 公司正在为政府部门部署解决方案,包括为军事卫生系统提供数字化行为健康解决方案 [14][57][58] - 政府部门部署进展顺利,预计第四季度完成企业级部署 [73][74] 公司战略和发展方向及行业竞争 - 公司正在优化组织架构,提高效率和盈利能力 [61][62][63][64][65][66][67] - 公司重新定义了目标市场和销售策略,将重点放在毛利率较高的细分市场 [92][93][94][95][96][97] - 公司认为行业内一些公司退出虚拟医疗业务并不意味着这一领域的机会已经消失,而是表明整合现有医疗资源的重要性 [51][52][53][54] 管理层对经营环境和未来前景的评论 - 管理层对公司2024年及未来几年的增长和盈利能力目标保持信心 [8][22][38][39][40] - 管理层认为公司的技术平台和混合医疗服务模式具有竞争优势,有助于获得更多客户和提高毛利率 [12][13][49][50] 问答环节重要的提问和回答 问题1 **Charles Rhyee 提问** 询问公司最近的客户续约情况,续约期限、新增功能等 [44][45][46][47][48] **Ido Schoenberg 回答** 公司客户续约期限大约3年,客户通常会在续约时增加新的功能,如虚拟primary care、自动化交互等 [45][46][47][48][49] 问题2 **Craig Hettenbach 提问** 询问公司实现盈亏平衡的关键变量和潜在的利好或不利因素 [61][62][63][64][65][66] **Robert Shepardson 回答** 公司预计毛利率将大幅提升,Converge相关研发投入将大幅下降,销售费用也有望下降,这些都将有助于实现盈亏平衡 [62][63][64][65] 问题3 **Jailendra Singh 提问** 询问Change Healthcare安全事件和大客户迁移对公司本季度业绩的具体影响 [77][78][79][80][81][82] **Ido Schoenberg 和 Robert Shepardson 回答** Change Healthcare事件导致公司本季度访问量同比下降,但剔除该影响后访问量应该持平。大客户迁移也造成了一定的短期干扰,但最终顺利完成 [79][80][81][82]

For the quarter ended March 2024, American Well Corporation (AMWL) reported revenue of $59.52 million, down 7% over the same period last year. EPS came in at -$0.25, compared to -$0.24 in the year-ago quarter. The reported revenue represents a surprise of -2.58% over the Zacks Consensus Estimate of $61.1 million. With the consensus EPS estimate being -$0.18, the EPS surprise was -38.89%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations ...

American Well Corporation (AMWL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -38.89%. A quarter ago, it was expected that this company would post a loss of $0.19 per share when it actually produced a loss of $0.17, delivering a surprise of 10.53%. Over the last four quarters, the company ...

公司业务 - Amwell是一家领先的企业平台和软件公司，数字化实现混合护理[37] - Converge平台是公司的最新企业平台软件版本，旨在数字化实现统一、可扩展的医疗体验[38] - 公司的商业模式是基于订阅销售企业平台和软件服务，提供专业服务和Carepoint设备，以支持数字护理解决方案[40] 财务状况 - 2024年第一季度，公司的订阅费收入分别为2490万美元和2870万美元[41] - 公司的关键指标之一是数字护理利用率，2024年第一季度完成了总共170万次访问[44] - 公司的服务和Carepoint设备收入分别为360万美元和280万美元[43] - 公司截至2024年3月31日和2023年12月31日的现金及现金等价物分别为3.086亿美元和3.720亿美元，用于多项增长和投资计划以及营运资金用途[67] 现金流 - 2024年3月31日，公司经营活动产生的净现金流为-5,975.6万美元，较2023年同期的-2,914.8万美元有所增加[66] - 公司截至2024年3月31日没有债务，预计未来几年将继续产生运营亏损[68] - 2024年3月31日，公司经营活动现金使用为5,980万美元，主要原因是公司的净亏损为7,340万美元[69] - 公司2024年3月31日的投资活动现金使用为460万美元，主要包括资本化软件开发成本和对少数持股合资企业的投资[71] - 2024年3月31日，公司融资活动现金提供为100万美元，主要来自员工股票购买计划[72] 法规监管 - 公司的运营受到美国联邦、州和地方法规以及国际法规的监管，特别是在COVID-19大流行期间[45]

Exhibit 99.1 AMWELL ANNOUNCES RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2024 BOSTON, May 1, 2024 – Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced financial results for the first quarter of 2024. “In Q1, we made significant strides forward. We are completing critical milestones to deploy our solution for the Military Health System, working alongside the Leidos Partnership for Defense Health. We also successfully migrated a large portion of our visit volume onto our Converge pla ...

Amwell公司财报发布 - Amwell将于2024年5月1日公布第一季度运营结果[1] - Amwell管理团队将在东部时间下午5点举行电话会议和网络直播[2] - Amwell提供领先的混合护理平台，连接提供者、付款人、患者和创新者，为更多人提供更便宜、更高质量的护理[4]